Skip to main content

Table 4 Pharmacokinetic parameters of amodiaquine and desethylamodiaquine (median, IQR) following artesunate-amodiaquine fixed-dose combination treatment of Ghanaian patients with uncomplicated P. falciparum malaria, by age category

From: Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malaria

Parameter

Age category (years)

p-value

All ages

 < 1

1–4

 ≥ 5

n = 223

n = 9

n = 125

n = 89

Amodiaquine

 AUC0-∞ (ng h /ml)

1318 (583–3549)

4201 (2773–17,909)

1994 (642–5199)

875 (400–1,434)

 < 0.001

 Cmax (ng/ml)

18.8 (9.8–50.7)

49.6 (21.7–107.0)

27.7 (14.7–70.0)

11.6 (6.7–18.8)

 < 0.001

 Tmax (days)

2 (1–3)

1 (1–2)

2 (1–3)

2 (1–3)

0.71

 Cl/F (L kg−1 h−1)

25.9 (8.6–56.0)

6.7 (1.4–11.2)

15.7 (7.0–47.1)

39.6 (18.7–76.9)

 < 0.001

 Vd/F (L kg−1)

1,195 (416–2,735)

325 (98–1141)

859 (359–2,613)

1,840 (861–3,656)

0.008

 t½ (hours)

47.4 (32.4–72.8)

54.1 (24.6–148.7)

48.8 (32.6–87.9)

41.7 (32.4–56.1)

0.24

 

n = 227

n = 9

n = 127

n = 91

 

Desethylamodiaquine

 AUC0-∞ (ng h /ml)

116,100 (70,325–203,110)

163,020 (94,262–255,562)

124,508 (79,736–225,582)

105,596 (56,986–159,382)

0.057

 Cmax (ng/ml)

565 (349–827)

365 (266–665)

604 (377–937)

528 (260–720)

0.046

 Tmax (days)

3 (2–3)

2 (2–3)

3 (2–3)

3 (2–3)

0.33

 Cl/F(L kg−1 h−1)

0.26 (0.16–0.46)

0.19 (0.11–0.31)

0.24 (0.16–0.41)

0.31 (0.16–0.56)

0.071

 Vd/F (L kg−1)

67.5 (43.0–126.8)

57.0 (40.1–100.5)

62.3 (42.9–124.6)

72.9 (45.3–150.2)

0.49

 t ½ (hours)

196.4 (152.8–276.1)

237.8 (204.6–280.3)

187.6 (155.1–276.1)

200.1 (137.5–268.6)

0.60

  1. IQR Interquartile range, AUC0-∞ Area under the concentration versus time curve from time zero to infinity, ng.h /ml nanogram hour per milliliter, Cmax = Observed maximum concentration, ng/ml nanogram per milliliter, Tmax time to maximum concentration, CL/f apparent clearance, Vd/f apparent volume of distribution, t½ = elimination half-life